# Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)

> **NCT01368939** · — · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 150 (estimated)

## Conditions studied

- Breast Lesions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01368939
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2012-09
- **Final completion:** 2013-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2012-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368939, "Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT01368939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*